FDA Inspection
S2 Medical IncS2 Medical Inc – FDA Inspection, May 3, 2013
Record Details
This FDA Inspection record concerns S2 Medical Inc, with an inspection on May 3, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- S2 Medical Inc
- Inspection Date
- May 3, 2013
- Product Type
- Biologics
View Company Profile
ID · 9b4fb8bf-0097-4555-b106-1578faa19b4c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 833296
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 1271.320(a)Procedures re complaints
Full citation text and observation details available on the Dashboard.
Other FDA inspections of S2 Medical Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for S2 Medical Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.